Association of Serum Neurofilament Light Chain Levels at Disease Onset with Disability Worsening in Patients with a First Demyelinating Multiple Sclerosis Event Not Treated with High-Efficacy Drugs

  1. Monreal, E.
  2. Fernández-Velasco, J.I.
  3. García-Sánchez, M.I.
  4. Sainz De La Maza, S.
  5. Llufriu, S.
  6. Álvarez-Lafuente, R.
  7. Casanova, B.
  8. Comabella, M.
  9. Ramió-Torrentà, L.
  10. Martínez-Rodríguez, J.E.
  11. Brieva, L.
  12. Saiz, A.
  13. Eichau, S.
  14. Cabrera-Maqueda, J.M.
  15. Villarrubia, N.
  16. Espiño, M.
  17. Pérez-Miralles, F.
  18. Montalbán, X.
  19. Tintoré, M.
  20. Quiroga-Varela, A.
  21. Domínguez-Mozo, M.I.
  22. Rodríguez-Jorge, F.
  23. Chico-García, J.L.
  24. Lourido, D.
  25. Álvarez-Cermeño, J.C.
  26. Masjuan, J.
  27. Costa-Frossard, L.
  28. Villar, L.M.
  29. Show all authors +
Journal:
JAMA Neurology

ISSN: 2168-6157 2168-6149

Year of publication: 2023

Volume: 80

Issue: 4

Pages: 397-403

Type: Article

DOI: 10.1001/JAMANEUROL.2023.0010 GOOGLE SCHOLAR

Sustainable development goals